Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression-Reference-Cited by-同舟云学术

Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression

Published:2003-11 Issue:10 Volume:54 Page:1105-1117
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Harvey Brian H,McEwen Bruce S,Stein Dan J

Funder

South African Medical Research Council

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference131 articles.

1. Metabolic rate in the right amygdala predicts negative affect in depressed patients;Abercrombie;Neuroreport,1998

2. Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression;Altamura;Eur Neuropsychopharmacol,1995

3. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia;Altshuler;Arch Gen Psychiatry,1998

4. Selective serotonin reuptake inhibitors versus tricyclic antidepressants;Anderson;J Affect Disorders,2000

5. Antidepressant-induced regulation of 5HT1B mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation;Anthony;J Neurosci Res,2000

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safe Deprescribing of Antidepressants;The Maudsley Deprescribing Guidelines – Antidepressants, Benzodiazepines, Gabapentinoids and Z‐drugs;2024-08-30

2. Case 11: How slow can you go? Selective serotonin reuptake inhibitor (SSRI) withdrawal and discontinuation in an adolescent;Case Studies: Stahl's Essential Psychopharmacology;2023-11-09

3. Antidepressant discontinuation syndrome: A state-of-the-art clinical review;European Neuropsychopharmacology;2023-01

4. Early Trauma Is Associated with Poor Pharmacological Treatment Response in Patients with Panic Disorder;Psychiatry Investigation;2021-03-25

5. What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications;Therapeutic Advances in Psychopharmacology;2021-01